Summary
This International Myopia Institute consensus report synthesises evidence from over 85 multidisciplinary experts on myopia control strategies in response to epidemic-level prevalence in some countries. The work critically reviews animal models, genetic studies, and clinical trial evidence to establish definitions, classify disease, identify risk factors for onset and progression, and provide ethical guidance on intervention application. Seven themed reports form the basis for clinical management recommendations and research standards in the field.
UK applicability
The findings are applicable to UK clinical practice and eye care policy, particularly given rising myopia prevalence in British children. The report's guidance on intervention validation and ethical application would inform UK optometric and ophthalmological standards and public health approaches to myopia management.
Key measures
Myopia prevalence, onset and progression rates, effectiveness of control interventions, clinical trial methodologies, genetic risk factors
Outcomes reported
The report synthesises evidence from animal models, genetics, clinical studies, and randomised controlled trials on myopia control interventions. It provides critical review and recommendations across seven key areas: definition and classification of myopia, experimental models, genetics, interventions, clinical trial design, industry guidelines, and management practices.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.